Top news
The next generation Covid-19 vaccines seeking a slice of the market
By Donato Paolo Mancini, Hannah Kuchler & Nikou Asgari
Why big pharma had a responsibility to profit from the pandemic
By James Boland
Pfizer advances clinical trials for 5- to 11-year-olds at lower doses
By Erin Schumaker
All coverage
FDA panel split on approach to COVID-19 vaccines for younger children
By Joanne Eglovitch & Michael Mezher
Here's what you should know about COVID-19 vaccine booster shots
By Erin Garcia de Jesús & Erin Garcia
Reports of Severe Covid or Death After Vaccination Are Rare, but Not Unexpected (Published 2021)
By Emily Anthes
Rich countries are buying up all the Covid-19 vaccines
By Annalisa Merelli
Pfizer to test COVID-19 vaccine in larger group of children below 12
By Michael Erman & Ankur Banerjee